Mesenchymal stem cells alleviate retinopathy and visual dysfunction induced by traumatic brain injury

Key Points

• Visual dysfunction is alleviated with mesenchymal stem cell treatment after traumatic brain injury, leading to improved outcomes.
• The study highlights a 30% reduction in visual impairment symptoms among treated subjects compared to controls.
• This observational analysis correlates the administration of mesenchymal stem cells with enhanced neuroprotection post-injury.
• These findings underscore the need for further investigation into stem cell therapies for brain and visual health.